Neuromedin S (Mouse)

Documents

Leu-Pro-Arg-Leu-Leu-Arg-Leu-Asp-Ser-Arg-Met-Ala-Thr-Val-Asp-Phe-Pro-Lys-Lys-Asp-Pro-Thr-Thr-Ser-Leu-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH₂
: (M.W. 4259.0) C₁₉₄H₃₁₄N₅₈O₄₈S
: Food Intake Suppressor / Regulator of Circadian Rhythm

Package	Price(Yen)	Availability
Vial 0.1 mg	12,000	Ships within 1-3 business days
Bulk Request

Solubility: H₂O (0.1 mM)

K. Mori, M. Miyazato, T. Ida, N. Murakami, R. Serino, Y. Ueta, M. Kojima, and K. Kangawa, EMBO J., 24, 325 (2005). (Original)
T. Ida, K. Mori, M. Miyazato, Y. Egi, S. Abe, K. Nakahara, M. Nishihara, K. Kangawa, and N. Murakami, Endocrinology, 146, 4217 (2005). (Pharmacol.)
E. Vigo, J. Roa, M. López, J.M. Castellano, R. Fernandez-Fernandez, V.M. Navarro, R. Pineda, E. Aguilar, C. Diéguez, L. Pinilla, and M. Tena-Sempere, Endocrinology, 148, 813 (2007). (Pharmacol.; Effect on LH Secretion)
T. Sakamoto, K. Mori, K. Nakahara, M. Miyazato, K. Kangawa, H. Sameshima, and N. Murakami, Biochem. Biophys. Res. Commun., 361, 457 (2007). (Pharmacol.; Antidiuretic Effect)
M. Jászberényi, Z. Bagasi, B. Thurzó, I. Földesi, and G. Telegdy, Horm. Behav., 52, 631 (2007). (Pharmacol.; Endocrine & Behavioral Effect)
M. Miyazato, K. Mori, T. Ida, M. Kojima, N. Murakami, and K. Kangawa, Regul. Pept., 145, 37 (2008). (Review)
M. Mori, K. Mori, T. Ida, T. Sato, M. Kojima, M. Miyazato, and K. Kangawa, Front. Endocrinol., 3, 152 (2012). (Review)
K. Nakahara, A. Akagi, S. Shimizu, S. Tateno, A.W. Qattali, K. Mori, M. Miyazato, K. Kangawa, and N. Murakami, Biochem. Biophys. Res. Commun., 470, 930 (2016). (Pharmacol.)

Data Sheet